Marlio Charles Mosseri, 10% Owner at Nuvectis Pharma, Inc. (NVCT), bought 26,180 shares at $17.71 ($464K) on 2023-06-21, disclosed to the SEC on 2023-06-23.
Open-market purchase of $464k NVCT by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.71 | 6,091 | $108K | 23.3% |
| 2 | $17.71 | 6,091 | $108K | 23.3% |
| 3 | $17.73 | 6,999 | $124K | 26.7% |
| 4 | $17.73 | 6,999 | $124K | 26.7% |
| Total | $17.72 avg | 26,180 | $464K | 100% |
| Filing → |
| NVCT | BUY | 2025-06-24 | $45K | — | Filing → |
| NVCT | BUY | 2025-06-20 | $495K | — | Filing → |
| NVCT | BUY | 2025-05-13 | $343K | — | Filing → |